Eugene Durenard
Vermögen: 90 998 $ am 31.05.2026
Vermögen: 90 998 $ am 31.05.2026
Eugene Durenard is the founder of Orion Investment Management Ltd., founded in 2006.
Dr. Durenard is the founder of Global Better Health, founded in 2018.
Dr. Durenard is the founder of Hyperbolic Holdings GmbH, founded in 2018, and holds the title of Chief Executive Officer since 2018.
Dr. Durenard is the founder of Healthcare Impact Foundation, founded in 2017, and holds the title of Trustee since 2017.
Dr. Durenard currently works at Co-Diagnostics, Inc. as an Independent Director since 2019.
Dr. Durenard earned a doctorate degree from Harvard University in 1995.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.05.2026 | 10’668 ( 0.3% ) | 90 998 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CO-DIAGNOSTICS, INC. | Direktor/Vorstandsmitglied | 25.06.2019 |
Hyperbolic Holdings GmbH | Vorstandsvorsitzender | 01.02.2018 |
Healthcare Impact Foundation | Gründer | 01.09.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Orion Investment Management Ltd.
Orion Investment Management Ltd. Investment ManagersFinance Provides investment services | Gründer | - |
Global Better Health | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orion Investment Management Ltd.
Orion Investment Management Ltd. Investment ManagersFinance Provides investment services | Finance |
Co-Diagnostics, Inc.
Co-Diagnostics, Inc. BiotechnologyHealth Technology Develops molecular diagnostics products and tests that represents a radical new advancement in the understanding of the molecular interactions of DNA | Health Technology |
Hyperbolic Holdings GmbH | |
Healthcare Impact Foundation | |
Global Better Health |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen